Key Dates

Related Announcements

• March 17, 2023 - Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional). See NOFO PAR-23-122.

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to correct the instructions for the Specific Aims attachment in applications submitted to PAR-23-122 “Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)”. The Notice of Funding Opportunity (NOFO) has been updated to correct a typographical error.

The below section of the NOFO is revised accordingly.  

Section IV. Application and Submission Information

2. Content and Form of Application Submission

PHS 398 Research Plan

Currently reads (deleted text noted in italics):

letterSpecific Aims: In addition to the scientific specific aims in alignment with a participating ICO's research mission, succinctly list the specific aim(s) of the DEIA proposed activities (e.g., training, mentoring, networking, cohort-building, career development, or psychosocial intervention to support entry and persistence of individuals from diverse backgrounds, including those from underrepresented groups in the biomedical research enterprise). DEIA activities must focus on enhancing diversity in the biomedical research enterprise within the United States and territories. State concisely the broader goals of the proposed DEIA activities and summarize the expected outcome(s), including the impact that the results of the proposed activities will have on the biomedical research enterprise.

Modified to read: 

Specific Aims: In addition to the scientific specific aims in alignment with a participating ICO's research mission, succinctly list the specific aim(s) of the DEIA proposed activities (e.g., training, mentoring, networking, cohort-building, career development, or psychosocial intervention to support entry and persistence of individuals from diverse backgrounds, including those from underrepresented groups in the biomedical research enterprise). DEIA activities must focus on enhancing diversity in the biomedical research enterprise within the United States and territories. State concisely the broader goals of the proposed DEIA activities and summarize the expected outcome(s), including the impact that the results of the proposed activities will have on the biomedical research enterprise.

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

NIGMS ReWARD
National Institute of General Medical Sciences (NIGMS)
Email: NIGMSReWARD@nigms.nih.gov